Navigation Links
Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
Date:10/8/2007

LAUSANNE, Switzerland, October 8 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in oncology and serious medical conditions, presented Professors Minoru Toyota and Keiichi Nakayama with the 2007 JCA-Mauvernay Award for their outstanding oncology research work. The Awards were presented during the General Assembly of the 66th Annual Conference of the JCA in Yokohama, Japan, by Professor Setsuo Hirohashi, President of the Japanese Cancer Association (JCA) and Dr Rolland-Yves Mauvernay, Founder and President of Debiopharm Group.

The work of Professor Toyota from the First Department of Internal Medicine, Sapporo Medical University, focuses on "DNA methylation as a new target for therapy in cancer". His applied research may lead to novel strategies for developing molecular markers and cancer therapies. DNA methylation of genes could be a useful molecular marker to predict response to chemotherapeutic drugs. The basic research work conducted by Professor Nakayama from the Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, focuses on "Ubiquitin ligases involved in cell-cycle control and cancer". His work shows that deregulation of the proteolytic system might result in uncontrolled proliferation, genomic instability and cancer. A better understanding of the ubiquitylation machinery will provide new insights into the regulatory biology of cell-cycle transitions and the development of anti-cancer drugs.

"Our goal with this Award is to recognise and reward excellent research conducted by Japanese scientists and to give them the opportunity to show their work to fellow researchers," said Kamel Besseghir, CEO of Debiopharm S.A. "This may increase the chances of their discoveries leading to the development of new medicines."

In its third year, the JCA-Mauvernay Award is organised jointly by the JCA and Debiopharm to honour innovative fundamental and clinical oncology research and to encourage Japanese scientists to make their work available outside Japan.

In August, with the Ecole Polytechnique Federale of Lausanne, Debiopharm presented the "Debiopharm Life Sciences Award" designed to mentor and motivate young innovative European researchers in the field of life sciences. Next month, the Company will reward a Chinese scientist with the "Debiopharm-CCRF China Award".

About Debiopharm Group

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. Debiopharm develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm has developed three products with global combined sales in excess of US$2.6 billion in 2006.

For more information on Debiopharm Group, please visit: http://www.debiopharm.com.


'/>"/>
SOURCE The Debiopharm Group
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Japanese delegates highlight Wisconsin at BIO Chicago
2. Japanese telecom opens liason office at UW-Platteville
3. Promega, Japanese lab announce partnership
4. Japanese institute installs Imago system
5. Sonic Foundry makes Japanese version of lead product
6. OpGen forges agreement with Japanese importer
7. Japanese biotech is booming and linked with Midwest
8. Japanese institute will develop for UWs Croquet platform
9. 40 Midwest biotech organizations to explore Japanese partnerships
10. Japanese Continue Relentless Biotech Stake in Midwest
11. Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  Allergan plc (NYSE: AGN ) a leading ... , Allergan,s CEO and President, will be featured as ... the RBC Capital Markets Healthcare Conference on Tuesday, February ... York Palace Hotel in New York, NY ... can be accessed on Allergan,s Investor Relations web site ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a fully-integrated network ... two long-standing principal investigators (PI) to the roles of Chief Medical Officer, Clinical ... Dr. Laurence Chu, a Benchmark Research PI in the Austin office, will assume ...
(Date:2/10/2016)... ... 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused ... latest InGaAs PIN diode standard packages feature a TO-46 metal can with active areas ...
(Date:2/10/2016)... Mateo, CA (PRWEB) , ... February 10, 2016 ... ... of Multiplex Testing (PROMPT), a research registry built on the secure online PatientCrossroads ... September 2014. More than 1,600 participants have joined the PROMPT study, which seeks ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):